COT Meeting: 7th May 2019
On this page
Skip the menu of subheadings on this page.Meeting Agenda
- Apologies for absence
- Draft minutes of March meeting TOX/MIN/2019/02
- Matters arising
- Male reproductive toxicity of a novel feed additive, 3-nitro-oxypropanol (3-NOP) (Reserved Business). TOX/2019/16
- Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Fusarenon-X. TOX/2019/17
- Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Cyclopiazonic acid (CPA). TOX/2019/18
- Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. Patulin. TOX/2019/19
- Review of potential risks from 2-MCPD, 3-MCPD and glycidol and their fatty acid esters in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/20
- Scoping paper on the potential risks from polycyclic aromatic hydrocarbons (PAHs) in the diet of infants aged 0 to 12 months and children aged 1 to 5 years. TOX/2019/21
- Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years – Additional information on TAs. TOX/2019/22
- Committee statement on phosphate-based flame retardants and the potential for neurodevelopmental toxicity – second draft TOX/2019/23
- Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes):
- Toxicity assessment of flavourings used in E(N)NDS: Vanillin. TOX/2019/24
- Toxicity assessment of flavourings used in E(N)NDS: Cinnamaldehyde TOX/2019/25
- Update paper for information: FSA Scientific Advisory Committees (SACs) update. TOX/2019/26
- Any other business
Date of next meeting 2nd July 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.
Media discussed during the meeting
TOX 2019 - 17
Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Fusarenon-X
TOX 2019 - 18
Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Cyclopiazonic acid (CPA)
TOX 2019 - 19
Review of potential risks from mycotoxins in the diet of infants aged 0 to 12 months and children aged 1 to 5 years - Patulin
TOX 2019 - 20
Review of potential risks from 2-monochloropropanediol (MCPD), 3-MCPD and glycidol and their fatty acid esters in the diet of infants aged 0 to 12 months and children aged 1 to 5 years.
TOX 2019 - 21
Scoping paper on the potential risks from polycyclic aromatic hydrocarbons (PAHs) in the diet of infants aged 0 to 12 months and children aged 1 to 5 years
TOX 2019 - 22
Review of potential risks from contaminants in the diet of infants aged 0 to 12 months and children aged 1 to 5 years – additional information on tropane alkaloids (TAs)
TOX 2019 - 23
Committee statement on phosphate-based flame retardants (PFRs) and the potential for neurodevelopmental toxicity – second draft
TOX 2019 - 24
Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes): Toxicity assessment of flavourings used in E(N)NDS: Vanillin
TOX 2019 - 25
Potential toxicological risks from electronic nicotine (and non-nicotine) delivery systems (E(N)NDS – e-cigarettes):Toxicity assessment of flavourings used in E(N)NDS: Cinnamaldehyde
The final minutes of the meeting of the Committee held on 7th May 2019 at Broadway House Conference Centre, Tothill St, London, SW1H 9NQ.